Hennion & Walsh Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Trust Investment Grade Municipals
VGM
|
+$4.8M |
| 2 |
Nuveen Municipal High Income Opportunity Fund
NMZ
|
+$4.39M |
| 3 |
BlackRock MuniYield Quality Fund
MQY
|
+$4.26M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$3.84M |
| 5 |
Olema Pharmaceuticals
OLMA
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$19.8M |
| 2 |
ETNB
89bio
ETNB
|
+$3.65M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
+$3.59M |
| 4 |
Rocket Lab Corp
RKLB
|
+$3.39M |
| 5 |
Invesco Municipal Opportunity Trust
VMO
|
+$3.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.53% |
| 2 | Healthcare | 11.66% |
| 3 | Financials | 9.01% |
| 4 | Industrials | 7.22% |
| 5 | Consumer Discretionary | 3.38% |
Similar funds
Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.
- Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
- Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
- Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
- Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
- Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
- Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
- Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.
Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.